These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3921686)

  • 1. Effect of ranitidine on gastric acid hypersecretion in an infant with short bowel syndrome.
    Hyman PE; Garvey TQ; Harada T
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):316-9. PubMed ID: 3921686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to intravenous ranitidine.
    Hyman PE; Garvey TQ; Abrams CE
    J Pediatr; 1987 May; 110(5):794-6. PubMed ID: 3572633
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastric acid hypersecretion in short bowel syndrome in infants: association with extent of resection and enteral feeding.
    Hyman PE; Everett SL; Harada T
    J Pediatr Gastroenterol Nutr; 1986; 5(2):191-7. PubMed ID: 3083080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time of administration influences gastric inhibitory effects of ranitidine.
    Johnston DA; Wormsley KG
    Scand J Gastroenterol; 1988 Nov; 23(9):1137-40. PubMed ID: 3247592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion.
    Holloway RH; Kuljian B; Eshelman F; McCallum RW
    Clin Pharmacol Ther; 1984 Feb; 35(2):203-7. PubMed ID: 6319068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine prophylaxis in acute gastric mucosal damage in critically ill pediatric patients.
    Lopez-Herce Cid J; Albajara Velasco L; Codoceo R; Delgado Dominguez MA; Jimenez E; Ruza Tarrio F
    Crit Care Med; 1988 Jun; 16(6):591-3. PubMed ID: 3371023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy.
    Prichard PJ; Jones DB; Yeomans ND; Mihaly GW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1986 Dec; 22(6):663-8. PubMed ID: 3567013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of basal gastric acid secretion on the pharmacodynamics of ranitidine.
    Sanders SW; Ballersteros MA; Hogan DL; Koss MA; Isenberg JI
    Chronobiol Int; 1991; 8(3):186-93. PubMed ID: 1794156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric secretion in response to a meal 12-13 h after ranitidine.
    Frislid K; Berstad A
    Scand J Gastroenterol; 1985 Aug; 20(6):711-4. PubMed ID: 3929374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cimetidine on gastric acid secretion and fractional emptying in short bowel syndrome.
    Murphy JP; King DR; Dubois A
    Surg Forum; 1978; 29():423-4. PubMed ID: 401211
    [No Abstract]   [Full Text] [Related]  

  • 13. Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study.
    Collen MJ; Wirshup JF
    Dig Dis Sci; 1995 Aug; 40(8):1687-90. PubMed ID: 7648968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-secretory effects and pharmacokinetics of low dose ranitidine.
    Koss MA; Hogan DL; Lane J; Steinbach JH; Isenberg JI
    Aliment Pharmacol Ther; 1993 Aug; 7(4):417-22. PubMed ID: 8218756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jejunal efflux in short bowel syndrome.
    Nightingale JM; Lennard-Jones JE; Walker ER; Farthing MJ
    Lancet; 1990 Sep; 336(8718):765-8. PubMed ID: 1976145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between inhibition of gastric acid secretion, plasma gastrin, and oxyntic mucosal histidine decarboxylase activity in the rat.
    Ryberg B; Mattsson H; Larsson H; Carlsson E
    Scand J Gastroenterol; 1989 Apr; 24(3):287-92. PubMed ID: 2734586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.
    Santucci L; Fiorucci S; Pelli MA; Calderazzo A; Biasini E; Calderazzo PL; Morelli A
    Dig Dis Sci; 1991 May; 36(5):583-7. PubMed ID: 2022159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.
    Collen MJ; Howard JM; McArthur KE; Raufman JP; Cornelius MJ; Ciarleglio CA; Gardner JD; Jensen RT
    Ann Intern Med; 1984 Jan; 100(1):52-8. PubMed ID: 6318628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of intravenous ranitidine after bolus and continuous infusion in patients with healed duodenal ulcers.
    Sanders SW; Buchi KN; Moore JG; Bishop AL
    Clin Pharmacol Ther; 1989 Nov; 46(5):545-51. PubMed ID: 2582711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of inhibition of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats.
    Seensalu R; Girma K; Romell B; Nilsson G
    Eur J Pharmacol; 1990 May; 180(1):145-52. PubMed ID: 2364999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.